AAT-AD/PD™ Focus Meeting 2020 – Vienna, Austria

We invite you to join us for the 2nd AAT-AD/PD Focus Meeting 2020 in Vienna, Austria. The first AAT-AD/PD Focus Meeting 2018 was held in Torino, Italy with 1337 participants.
The Meeting will present all the latest breakthroughs in treatment, translational R&D, early diagnosis, drug development and clinical trials in Alzheimer’s, Parkinson’s and other related neurological disorders.
A central theme will be to further advance innovative strategies in therapy and prevention, clinical trials and diagnostic markers discussed in the sessions and corridors at AD/PD 2019, in order to focus on driving successful collaborations among academia and industry, leading to the development of innovative therapies and ultimately providing for a better future for patients and families affected by neurodegenerative diseases.
Abstract Deadline: September 18, 2019
Early Registration Deadline: January 7, 2020
Join us 2-5 April 2020 in the beautiful city of Vienna, Austria.

Organizing Committee
- Abraham Fisher, Co-President
- Ezio Giacobini, Co-President
- Gabriel Gold, Executive Organizer
- Roger M. Nitsch, Executive Organizer
- Manfred Windisch, Executive Organizer

Themes:
- β-Amyloid Diseases
- Tauopathies
- α-Synucleinopathies
- TDP-43- and C9orf72-Related Diseases
- Limbic-predominant Age-related TDP-43 encephalopathy
- Vascular Dementia
- Lysosomal and Storage Diseases
- Psychiatric and Epileptic Symptoms.
- Patient Care and Support
Please see the website for a breakdown of the themes.

Topics:
- Disease Mechanisms, Pathophysiology
- Therapeutic Targets, Mechanisms for Treatment
- Drug Development, Clinical Trials and Trial Design
- Imaging and Biomarkers for Clinical Inclusion & Outcome Measures
- Epidemiology and Genetics in Clinical Trials
- Cell, Molecular & Systems Biology
- Translational Aspects
Please see the website for subtopics.